Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherCLINICAL INVESTIGATIONS

Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck

David R. Colnot, Jasper J. Quak, Jan C. Roos, Arthur van Lingen, Abraham J. Wilhelm, Gerard J. van Kamp, Peter C. Huijgens, Gordon B. Snow and Guus A.M.S. van Dongen
Journal of Nuclear Medicine December 2000, 41 (12) 1999-2010;
David R. Colnot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasper J. Quak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan C. Roos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur van Lingen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abraham J. Wilhelm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard J. van Kamp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter C. Huijgens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon B. Snow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guus A.M.S. van Dongen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 12 1999-2010
PubMed 
11138685

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online December 1, 2000.

Copyright & Usage 
© 2000

Author Information

  1. David R. Colnot,
  2. Jasper J. Quak,
  3. Jan C. Roos,
  4. Arthur van Lingen,
  5. Abraham J. Wilhelm,
  6. Gerard J. van Kamp,
  7. Peter C. Huijgens,
  8. Gordon B. Snow and
  9. Guus A.M.S. van Dongen
  1. Departments of Otolaryngology/Head and Neck Surgery, Nuclear Medicine, Clinical Chemistry, and Hematology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2001 to April 2025

AbstractFullPdf
Feb 20012218
Mar 200122921
Apr 2001213416
May 200101516
Jun 20013154
Jul 2001172
Aug 20010122
Sep 20011122
Oct 2001273
Nov 2001251
Dec 2001142
Jan 2002292
Feb 200261212
Mar 2002340
Apr 2002040
May 20023102
Jun 2002520
Jul 2002242
Aug 2002362
Sep 2002282
Oct 2002052
Nov 2002132
Dec 20023114
Jan 2003074
Feb 2003162
Mar 2003584
Apr 2003461
May 20032114
Jun 2003164
Jul 20034183
Aug 200312134
Sep 20031040
Oct 20039144
Nov 20031172
Dec 2003894
Jan 200429124
Feb 2004891
Mar 200415134
Apr 200417166
May 200416175
Jun 200433524
Jul 200441481
Aug 200419513
Sep 200411261
Oct 200415125
Nov 2004202210
Dec 200418220
Jan 200513122
Feb 200517203
Mar 200510244
Apr 20056114
May 20053112
Jun 200511475
Jul 2005380
Aug 20056100
Sep 20059156
Oct 200524202
Nov 200513131
Dec 2005993
Jan 2006822
Feb 2006755
Mar 2006643
Apr 2006531
May 2006446
Jun 2006832
Jul 2006431
Aug 20061117
Sep 20065134
Oct 20064146
Nov 2006241
Apr 2007652
May 20077134
Jun 20074101
Jul 2007575
Aug 2007554
Sep 2007231
Oct 2007997
Nov 20078125
Dec 20076124
Jan 2008892
Feb 2008665
Mar 20086109
Apr 2008785
May 2008986
Jun 200813176
Jul 200818125
Aug 200813121
Sep 200813134
Oct 20084115
Nov 20085109
Dec 2008474
Jan 2009297
Feb 20099164
Mar 200915185
Apr 20091075
May 20093106
Jun 20093138
Jul 20094224
Aug 20095193
Sep 20096273
Oct 200932144
Nov 20092753
Dec 2009433
Jan 20104710
Feb 2010584
Mar 20107103
Apr 20105135
May 20106117
Jun 2010495
Jul 2010630
Aug 20104124
Sep 201071511
Oct 2010882
Nov 2010585
Dec 2010663
Jan 20114112
Feb 20117157
Mar 2011186
Apr 2011774
May 201172612
Jun 2011932
Jul 20112897
Aug 20118157
Sep 2011171010
Oct 20116113
Nov 20117128
Dec 20111177
Jan 2012288
Feb 20121367
Mar 20121643
Apr 201216193
May 20125233
Jun 201212325
Jul 20126154
Aug 20129103
Sep 201214124
Oct 20122354
Nov 2012668
Dec 20126105
Jan 20131541
Feb 20136207
Mar 2013999
Apr 201324126
May 201316136
Jun 2013933
Jul 2013810
Aug 201312101
Sep 2013652
Oct 2013520
Nov 2013710
Dec 20131574
Jan 20141124
Feb 2014504
Mar 2014942
Apr 20141458
May 2014343
Jun 2014641
Jul 2014605
Aug 2014614
Sep 201414117
Oct 20141871
Nov 20141275
Dec 20142956
Jan 2015374
Feb 20151071
Mar 201517103
Apr 20151553
May 20151180
Jun 201511102
Jul 2015467
Aug 2015792
Sep 201510113
Oct 2015243
Nov 201518141
Dec 201526176
Jan 201618144
Feb 2016743
Mar 20161058
Apr 20161101
May 2016864
Jun 20161480
Jul 20163102
Aug 2016446
Sep 2016545
Oct 20168720
Nov 2016968
Dec 2016183
Jan 20177126
Feb 20175207
Mar 2017397
Apr 20174104
May 20173710
Jun 2017293
Jul 2017372
Aug 201751011
Sep 2017461
Oct 20172610
Nov 20171310
Dec 2017274
Jan 2018562
Feb 2018669
Mar 20182125
Apr 2018550
May 2018663
Jun 20182151
Jul 2018692
Aug 20181131
Sep 20182140
Oct 20185160
Nov 20181142
Dec 20186103
Jan 20193112
Feb 20198152
Mar 20195218
Apr 20193276
May 2019792
Jun 2019359
Jul 20193177
Aug 2019332
Sep 2019101
Oct 2019213
Nov 2019332
Dec 2019042
Jan 2020641
Feb 2020117
Mar 2020261
Apr 2020245
May 2020053
Jun 2020060
Jul 2020223
Aug 2020320
Sep 2020541
Oct 2020733
Nov 2020145
Dec 2020354
Jan 20213411
Feb 202162911
Mar 2021578
Apr 20212540
May 20216283
Jun 2021281
Jul 20217146
Aug 2021320
Sep 20215162
Oct 20214185
Nov 2021597
Dec 2021572
Jan 20227173
Feb 2022394
Mar 2022241
Apr 2022542
May 2022233
Jun 2022371
Jul 2022022
Aug 2022153
Sep 2022271
Oct 20225203
Nov 2022547
Dec 2022452
Jan 20237235
Feb 20230159
Mar 20231112
Apr 20231194
May 20232134
Jun 202301611
Jul 2023176
Aug 2023176
Sep 2023171
Oct 2023332
Nov 20235173
Dec 20231276
Jan 20241150
Feb 20244167
Mar 2024431
Apr 202433026
May 20245146
Jun 202482712
Jul 202441713
Aug 20243338
Sep 20242246
Oct 20244309
Nov 20243134
Dec 20244162
Jan 20250114
Feb 202531045
Mar 20254475
Apr 202548111
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 41, Issue 12
December 1, 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck
David R. Colnot, Jasper J. Quak, Jan C. Roos, Arthur van Lingen, Abraham J. Wilhelm, Gerard J. van Kamp, Peter C. Huijgens, Gordon B. Snow, Guus A.M.S. van Dongen
Journal of Nuclear Medicine Dec 2000, 41 (12) 1999-2010;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck
David R. Colnot, Jasper J. Quak, Jan C. Roos, Arthur van Lingen, Abraham J. Wilhelm, Gerard J. van Kamp, Peter C. Huijgens, Gordon B. Snow, Guus A.M.S. van Dongen
Journal of Nuclear Medicine Dec 2000, 41 (12) 1999-2010;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • How Far Have We Come with Solid (Nonhematologic) Tumor Radioimmunotherapy?
  • PubMed
  • Google Scholar

Cited By...

  • Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
  • Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
  • Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
  • Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
  • A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus.
  • Radioimmunotherapy of Head and Neck Cancer Xenografts Using 131I-Labeled Antibody L19-SIP for Selective Targeting of Tumor Vasculature
  • Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody u36 in the detection of lymph node metastases in head and neck cancer patients.
  • Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
  • Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response
  • Dosimetric Analysis of Radioimmunotherapy with 186Re-Labeled Bivatuzumab in Patients with Head and Neck Cancer
  • Phase I Therapy Study with 186Re-labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab) in Patients with Head and Neck Squamous Cell Carcinoma
  • 89Zr Immuno-PET: Comprehensive Procedures for the Production of 89Zr-Labeled Monoclonal Antibodies
  • Reinfusion of Unprocessed, Granulocyte Colony-stimulating Factor-stimulated Whole Blood Allows Dose Escalation of 186Relabeled Chimeric Monoclonal Antibody U36 Radioimmunotherapy in a Phase I Dose Escalation Study
  • Evaluation of Limited Blood Sampling in a Preceding 99mTc-Labeled Diagnostic Study to Predict the Pharmacokinetics and Myelotoxicity of 186Re-cMAb U36 Radioimmunotherapy
  • How Far Have We Come with Solid (Nonhematologic) Tumor Radioimmunotherapy?
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire